Skip to content
All news
ProductLaunch

FBI Approves Thermo Fisher's Rapid DNA Cartridge for Forensics

Thermo Fisher Scientific's Applied Biosystems RapidINTEL Plus cartridge has gained FBI approval for generating CODIS-searchable Rapid DNA crime scene profiles. This expands the company's role in forensic workflows and strengthens its long-term strategy.

July 20, 2026
2 min read
Source: Simply Wall St.
Share:

Key Numbers

dividend
US$0.47 per share
dividend payment date
October 15, 2026
dividend record date
September 15, 2026

Thermo Fisher Scientific (TMO) has received FBI approval for its Applied Biosystems RapidINTEL Plus cartridge, which can generate Rapid DNA profiles searchable in the CODIS database. This development enhances the company's position in the forensic market.

The Product

The RapidINTEL Plus cartridge is a rapid DNA analysis device that produces CODIS-compatible DNA profiles within hours, compared to days. It can be used at crime scenes or in labs to accelerate suspect identification.

Pricing and Availability

Thermo Fisher has not disclosed pricing details. It is expected to be available to government agencies and accredited forensic labs.

Competition

Thermo Fisher faces competition from companies like ANDE Corporation, which offer similar Rapid DNA solutions. The FBI approval gives Thermo Fisher a competitive edge.

Potential Impact on the Company

The approval is expected to boost Thermo Fisher's forensics segment revenue, especially as demand for rapid analysis solutions grows. It also reinforces the company's reputation as a trusted provider of law enforcement technologies.

Frequently Asked Questions

It is a rapid DNA analysis device from Thermo Fisher that can create CODIS-compatible DNA profiles in hours.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.